Research ArticleResearch Article

B7-H4 Expression and Increased Death Risk of Cancer Patients: A Meta-Analysis

Jing-ting JIANG, Chang-ping WU, Xiao ZHENG, Yao ZHAO, Bin XU, Bin-feng LU and Yue-ping SHEN
Clinical Oncology and Cancer Research December 2011, 8 (4) 229-234; DOI: https://doi.org/10.1007/s11805-011-0586-4

References

  1. ↵
    1. Aunoble B,
    2. Sanches R,
    3. Didier E, et al.
    Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 2000; 16: 567–576.
    OpenUrlPubMedWeb of Science
  2. ↵
    1. Nicosia SV,
    2. Bai W,
    3. Cheng JQ, et al.
    Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am 2003; 17: 927–943.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Sica GL,
    2. Choi IH,
    3. Zhu G, et al.
    B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18: 849–861.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Prasad DV,
    2. Richards S,
    3. Mai XM, et al.
    B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003; 18: 863–873.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Zang X,
    2. Loke P,
    3. Kim J, et al.
    B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A 2003; 100: 10388–10392.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Zou W,
    2. Chen L.
    Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008; 8: 467–477.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Kryczek I,
    2. Zou L,
    3. Rodriguez P, et al.
    B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203: 871–881.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Kryczek I,
    2. Wei S,
    3. Zhu G, et al.
    Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007; 67: 8900–8905.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Kryczek I,
    2. Wei S,
    3. Zou L, et al.
    Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 2006; 177: 40–44.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Anderson GL,
    2. McIntosh M,
    3. Wu L, et al.
    Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst 2010; 102: 26–38.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Jiang J,
    2. Zhu Y,
    3. Wu C, et al.
    Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunol Immunother 2010; 59: 1707–1714.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Krambeck AE,
    2. Thompson RH,
    3. Dong H, et al.
    B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A 2006; 103: 10391–10396.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Oikonomopoulou K,
    2. Li L,
    3. Zheng Y, et al.
    Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br J Cancer 2008.
  14. ↵
    1. Simon I,
    2. Katsaros D,
    3. Rigault de la Longrais I, et al.
    B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. Gynecol Oncol 2007; 106: 334–341.
    OpenUrlCrossRefPubMed
  15. ↵
    1. DerSimonian R,
    2. Laird N.
    Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Choi IH,
    2. Zhu G,
    3. Sica GL, et al.
    Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003; 171: 4650–4654.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Salceda S,
    2. Tang T,
    3. Kmet M, et al.
    The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005; 306: 128–141.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Sun Y,
    2. Wang Y,
    3. Zhao J, et al.
    B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006; 53: 143–151.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Zang X,
    2. Thompson RH,
    3. Al-Ahmadie HA, et al.
    B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A 2007; 104: 19458–19463.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Tringler B,
    2. Zhuo S,
    3. Pilkington G, et al.
    B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005; 11: 1842–1848.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Sun Y,
    2. Liu J,
    3. Cui X, et al.
    Clinical significance of expression of B7-H4 in colon and rectal cancer tissues. Journal Of Shandong University (Health Sciences) 2006; 44: 590–592.
    OpenUrl
  22. ↵
    1. Awadallah NS,
    2. Shroyer KR,
    3. Langer DA, et al.
    Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas 2008; 36: 200–206.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Yao Y,
    2. Wang X,
    3. Jin K, et al.
    B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells. J Neurooncol 2008; 89: 121–129.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Watanabe N,
    2. Gavrieli M,
    3. Sedy JR, et al.
    BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003; 4: 670–679.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Compaan DM,
    2. Gonzalez LC,
    3. Tom I, et al.
    Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem 2005; 280: 39553–39561.
    OpenUrlAbstract/FREE Full Text
    1. Gonzalez LC,
    2. Loyet KM,
    3. Calemine-Fenaux J, et al.
    A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci U S A 2005; 102: 1116–1121.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Sedy JR,
    2. Gavrieli M,
    3. Potter KG, et al.
    B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005; 6: 90–98.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords